2022 Pharmacotherapy Preparatory Review and Recertification Course -- Biostatistics: A Refresher, Study Designs: Fundamentals and Interpretation, Neurology

Saturday, April 23, 2022 from 1:45 PM to 5:30 PM CDT
at Academic and Research Building: First Floor, Room 111
Available for 3.75 hours of CPE credit
Activity Number: 0217-0000-22-012-L01-P
Pharmacotherapy Preparatory Review and Recertification Course is ideal for pharmacy professionals preparing for the Board of Pharmacy Specialties (BPS) Pharmacotherapy Specialty Certification Examination, for Board Certified Pharmacotherapy Specialists (BCPSs) seeking recertification through continuing education, and for those seeking a self-paced review and refresher of pharmacotherapy topics.

Developed and presented by board-certified pharmacotherapy specialists, the course provides a comprehensive review of the knowledge domains covered in the pharmacotherapy specialty. Using a case-based approach, the course strongly emphasizes the thought processes needed to solve patient care problems in each therapeutic area.

Learning Objectives

1. Describe differences between descriptive and inferential statistics.
2. Identify different types of data (nominal, ordinal, continuous [ratio and interval]) to determine an appropriate type of statistical test on the basis of the sample distribution, data type, and study design.
3. Describe strengths and limitations of different types of measures of central tendency (mean, median, and mode) and data spread (standard deviation, standard error of the mean, range, and interquartile range).
4. Describe hypothesis testing and decision errors; state the meaning of and distinguish between p-values and confidence intervals.
5. Describe the similarities and differences between statistical tests, and state how to apply and interpret them appropriately.
6. Define, compare, and contrast the concepts of internal and external validity, bias, and confounding in clinical study design, and identify potential sources in clinical trials.
7. Outline the hierarchy of evidence generated by various study designs, and compare and contrast the advantages and disadvantages of various study designs.
8. Compute, define, and evaluate odds, odds ratio, risk/incidence rate, risk ratio/relative risks (RRs), and other risk estimates.
9. Compute and evaluate number needed to treat and number needed to harm.
10. Define point and period prevalence, incidence rate, prevalence rate, absolute risk difference, and RR difference.
11. Describe the steps of the professional writing and peer-review processes.
12. Determine seizure type and appropriate use of antiepileptic drugs on the basis of their activity, adverse effects, and drug interactions for epilepsy and status epilepticus.
13. Establish appropriate interventions for primary and secondary prevention of stroke and appropriate treatment for acute stroke.
14. Initiate and monitor pharmacotherapy for Parkinson disease.
15. Differentiate between regimens for acute and prophylactic treatment of migraine, tension, and cluster headaches.
16. Identify appropriate therapies for individuals with multiple sclerosis.
17. Establish appropriate treatment for peripheral neuropathy.

Biostatistics: A Refresher 1:45 PM to 3:00 PM Speakers Speaker: Kevin M. Sowinski, Pharm.D., FCCP Professor of Pharmacy Practice, Purdue University College of Pharmacy Adjunct Professor of Medicine, Indiana University School of Medicine Indianapolis, Indiana View Biography Sowinski

Study Designs: Fundamentals and Interpretation 3:00 PM to 4:15 PM Speakers Speaker: Kevin M. Sowinski, Pharm.D., FCCP Professor of Pharmacy Practice, Purdue University College of Pharmacy Adjunct Professor of Medicine, Indiana University School of Medicine Indianapolis, Indiana View Biography Sowinski

Neurology 4:25 PM to 5:30 PM Speakers Speaker: Golden L. Peters, Pharm.D., FCCP, BCPS Associate Professor, Department of Pharmacy Practice St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis Saint Louis, Missouri View Biography Peters